BioNote

BioNote Revenue per Share

The Revenue per Share of BioNote (377740.KS) as of Oct 9, 2026 is 1,172.48 KRW. In the previous year, Revenue per Share was 1,013.98 KRW — a change of 15.63% (higher).

Revenue per Share

1,172.48KRW

YoY

15.63%

Last updated:

Revenue per Share of BioNote is 2025 1,172.48 KRW. Revenue per Share of BioNote was 2024 1,013.98 KRW. It decreases by 15.63% higher compared to the previous year.

The BioNote Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2019
385.23 KRW
Jan 1, 2020
6,074.73 KRW
Jan 1, 2021
6,108.95 KRW
Jan 1, 2022
4,708.24 KRW
Jan 1, 2023
882.66 KRW
Jan 1, 2024
1,013.98 KRW
Jan 1, 2025
1,172.48 KRW
Jan 1, 2026 (e)
1,928.41 KRW
The BioNote Revenue per Share history
YEARRevenue per ShareYoY
est1,928.41KRW+64.47%
1,172.48KRW+15.63%
1,013.98KRW+14.88%
882.66KRW-81.25%
4,708.24KRW-22.93%
6,108.95KRW+0.56%
6,074.73KRW+1,476.89%
385.23KRW—
Access this data via the Eulerpool API
Get Free API Key

BioNote Stock analysis

What does BioNote do? BioNote is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioNote stock

Revenue per Share of BioNote is 1,172.48 KRW in 2025.

Revenue per Share of BioNote changed from 1,013.98 KRW to 1,172.48 KRW, representing a 15.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share BioNote since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — BioNote

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — BioNote